JY016

· Biotech Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JY016, covering 2026-04-06 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: JY016 Injection in Patients With Advanced Solid Tumors Expressing EGFR [Phase 1, Phase 2]